Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688319'
s Days Inventory Range Over the Past 10 Years
Min: 461.92 Med: 859.16 Max: 433620
Current: 461.92
During the past 13 years, Chengdu Olymvax Biopharmaceuticals's highest Days Inventory was 433620.00. The lowest was 461.92. And the median was 859.16.
SHSE:688319's Days Inventory is ranked worse than 81.03% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688319: 461.92
Inventory Turnover measures how fast the company turns over its inventory within a year.
Chengdu Olymvax Biopharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chengdu Olymvax Biopharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.41.
Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Chengdu Olymvax Biopharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chengdu Olymvax Biopharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Chengdu Olymvax Biopharmaceuticals Days Inventory Related Terms
Chengdu Olymvax Biopharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Olymvax Biopharmaceuticals Days Inventory Chart
SHSE:688319 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Chengdu Olymvax Biopharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chengdu Olymvax Biopharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chengdu Olymvax Biopharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Chengdu Olymvax Biopharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Olymvax Biopharmaceuticals (SHSE:688319) has a Days Inventory of 456.57 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chengdu Olymvax Biopharmaceuticals and its competitors. This is 47% below median its historical median of 859.16. Over the past decade, Chengdu Olymvax Biopharmaceuticals' Days Inventory has ranged from 461.92 to 433,620.00. According to the industry distribution chart, Chengdu Olymvax Biopharmaceuticals ranks #517 out of 638 companies in the Biotechnology industry, placing it in the top 81%.
Is Chengdu Olymvax Biopharmaceuticals' Days Inventory too high?
Chengdu Olymvax Biopharmaceuticals' current Days Inventory of 456.57 is 47% below median its 10-year median of 859.16. Over the past 10 years, this metric has ranged from a low of 461.92 to a high of 433,620.00. The Biotechnology industry median Days Inventory is 183.20. Chengdu Olymvax Biopharmaceuticals' value of 456.57 is 149.2% above this industry median. Based on the distribution chart, Chengdu Olymvax Biopharmaceuticals ranks #517 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chengdu Olymvax Biopharmaceuticals has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chengdu Olymvax Biopharmaceuticals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chengdu Olymvax Biopharmaceuticals ranks #517 out of 638 companies for Days Inventory. This places Chengdu Olymvax Biopharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.20. Chengdu Olymvax Biopharmaceuticals' value of 456.57 is 149.2% above this benchmark. Historically, Chengdu Olymvax Biopharmaceuticals' own Days Inventory has ranged from 461.92 to 433,620.00 over the past decade. While the company's 10-year median is 859.16 vs. the industry median of 183.20, Chengdu Olymvax Biopharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chengdu Olymvax Biopharmaceuticals's current Days Inventory of 456.57 is 149.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chengdu Olymvax Biopharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chengdu Olymvax Biopharmaceuticals's current Days Inventory is 456.57, which is 47% below median its own 10-year median of 859.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengdu Olymvax Biopharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Chengdu Olymvax Biopharmaceuticals (SHSE:688319) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥23.17, compared to a current price of ¥25.63 — trading 10.6% above its estimated fair value. The current Days Inventory is 456.57, which is 47% below median its 10-year median of 859.16 and 149.2% above the Biotechnology industry median of 183.20. Chengdu Olymvax Biopharmaceuticals' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Chengdu Olymvax Biopharmaceuticals (SHSE:688319), the current Days Inventory is 456.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Overvalued in 2026?
Based on GuruFocus' analysis, Chengdu Olymvax Biopharmaceuticals stock appears to be overvalued.
The current stock price of ¥25.63 is trading 10.6% above its estimated GF Value™ of ¥23.17.
GuruFocus considers Chengdu Olymvax Biopharmaceuticals to be Modestly Overvalued.
Key valuation signals for SHSE:688319:
Days Inventory: 456.57 (47% below median its 10-year median of 859.16)
GF Value™: ¥23.17 vs. price of ¥25.63 (10.6% above fair value)
Industry Position: 149.2% above the Biotechnology median (#517 of 638)
No single metric tells the full story. See the SHSE:688319 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chengdu Olymvax Biopharmaceuticals Business Description
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
73GF Score
Get the complete analysis for SHSE:688319
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688319 has been successfully added to your 
